Fairvalue-Calculator Fairvalue-Calculator

ORION Corp (271560) Fair Value & Analysis

Consumer Defensive · KR · Market cap 5.2T KRW

Price125,500 KRW
Fair Value203,315 KRW
Upside+62.0%
Quality92/100
Evidence: High Range 145,500 KRW – 254,144 KRW

Analysis

ORION Corp (271560) currently trades at 125,500 KRW, while our model-based Fair Value estimate is 203,315 KRW — implying the stock looks roughly 62.0% undervalued today. We read business quality at 92/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

ORION Corp., together with its subsidiaries, engages in the manufacture and sale of various confectionery products in South Korea, China, and internationally. It offers pies, snacks, biscuits, candies, gums, and chocolates; protein drinks/powders and bars/balls bars; bar and oat products; and mineral water under the Dr.You, Market O, Market O Nature, and Jeju yongamsoo brands. The company also produces and distributes films; and provides in vitro diagnostics for early detection of cancer and vaccines for contagious diseases. In addition, it manufactures and sells food and beverage products; processes agriculture products; and manufactures pulp and paper products. The company was formerly known as Tongyang Confectionery Corporation and changed its name to Orion Corporation in 2003. ORION Corp. was founded in 1956 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.